
With the new regulatory guidelines concerning GCP, questions have arisen as to how best RBM plans can comply. These questions and answers will assist sponsors in assuring compliance.

With the new regulatory guidelines concerning GCP, questions have arisen as to how best RBM plans can comply. These questions and answers will assist sponsors in assuring compliance.


Aurinia Pharma has announced the selection of Worldwide Clinical Trials as its CRO for the AURORA study.


PAREXEL has announced the launch of its expanded Managed Access Programs service.

Examining the role of Clinical Research Malaysia in advancing industry-sponsored drug development in the country.


Clinerion has announced the release of its Patient Recruitment System Patient Finder tool for market access.

The 21st Century Cures Act, passed in December, contains provisions that many have questioned and criticized. This review of those provisions shows that progress in this sector is being made.


ArisGlobal has announced the release of the latest version of its clinical trial management software, agClinical 3.3.


A Brussels–based European Union conference on social rights set the stage for how access to healthcare should be widened with improved balance between innovation and affordability.


Nadir Benouali of MEDICODOSE Systems speaks on his experiences with investigational product nonadherence, its place in pharma and patient-centric ways to address it.

Lyft and Continuum Clinical announced a partnership that will provide transportation solutions for patients enrolled in clinical trials.

While wearable devices are mainly an advantageous way to collect data from monitoring a trial participant’s progress, there are scientific and operational considerations to be aware of.


Image Analysis Group (IAG) has announced a partnership with Boston Medical Center/Boston University School of Medicine (BMC/BUSM).

The Expert Determination standard of protecting patient privacy can answer the growing demand for better data for research and analytics in healthcare.

A revised version of the Common Rule will remove the need for additional informed consent when studying biospecimen data of clinical trial participants.



Bio-Optronics Inc. has announced the release of an upgrade for Clinical Conductor CTMS, which now includes patient management for care quality.

The CRO industry is experiencing exponential growth as a result of higher demand from the biopharma industry and an increased investment in R&D. This evaluation of QuintilesIMS attempts to provide some hints as to how this sector is advancing in the biopharma industry.

Updated employee announcements, business news and recognition in the industry today.



CRF Health has announced the launch and FDA clearance of its Entra BLE Smart wireless glucose meter.